Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis

ClinicalTrials.gov ID: NCT02147899

Public ClinicalTrials.gov record NCT02147899. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 12:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis

Study identification

NCT ID
NCT02147899
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Symbiomix Therapeutics
Industry
Enrollment
215 participants

Conditions and interventions

Interventions

  • SYM-1219 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2014
Primary completion
Sep 30, 2014
Completion
Sep 30, 2014
Last update posted
Nov 12, 2020

2014

United States locations

U.S. sites
16
U.S. states
12
U.S. cities
16
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294
Women's Health Care Research Corp. San Diego California 92123
Women's Medical Research Group, LLC Clearwater Florida 33759
Healthcare Clinical Data, Inc. North Miami Florida 33161
Atlanta North Gynecology, P.C Roswell Georgia 30075
Wayne State University Detroit Michigan 48201
Saginaw Valley Medical Research Group, LLC Saginaw Michigan 48604
Lawrence OB-GYN Clinical Research, LLC Lawrenceville New Jersey 08648
Scott Eder MD Plainsboro New Jersey 08536
Eastern Carolina Women's Center New Bern North Carolina 28562
Clinical Research of Philadelphia, LLC Philadelphia Pennsylvania 19114
The Jackson Clinic, PA Jackson Tennessee 38305
TMC Life Research, Inc. Houston Texas 77054
Clinical Trials of Texas, Inc. San Antonio Texas 78229
Tidewater Physicians for Women Virginia Beach Virginia 23502
University of Washington, Harborview Medical Center Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02147899, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 12, 2020 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02147899 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →